Authors:
Senekowitsch-Schmidtke, R
Schuhmacher, C
Becker, KF
Nikula, TK
Seidl, C
Becker, I
Miederer, M
Apostolidis, C
Adam, C
Huber, R
Kremmer, E
Fischer, K
Schwaiger, M
Citation: R. Senekowitsch-schmidtke et al., Highly specific tumor binding of a Bi-213-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer, CANCER RES, 61(7), 2001, pp. 2804-2808
Citation: C. Schuhmacher et al., Preoperative down-staging in advanced gastric carcinoma: wishful thinking or reality?, ZBL CHIR, 125(4), 2000, pp. 333-340
Authors:
Schuhmacher, C
Becker, KF
Reich, U
Schenk, U
Mueller, J
Siewert, JR
Hofler, H
Citation: C. Schuhmacher et al., Rapid detection of mutated E-cadherin in peritoneal lavage specimens from patients with diffuse-type gastric carcinoma, DIAGN MOL P, 8(2), 1999, pp. 66-70
Authors:
Schuhmacher, C
Becker, I
Oswald, S
Atkinson, MJ
Nekarda, H
Becker, KF
Mueller, J
Siewert, JR
Hofler, H
Citation: C. Schuhmacher et al., Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations, VIRCHOWS AR, 434(6), 1999, pp. 489-495
Authors:
Becker, KF
Kremmer, E
Eulitz, M
Becker, I
Handschuh, G
Schuhmacher, C
Muller, W
Gabbert, HE
Ochiai, A
Hirohashi, S
Hofler, H
Citation: Kf. Becker et al., Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody, AM J PATH, 155(6), 1999, pp. 1803-1809